Inventor · disambiguated record
Gerald Bacher
Also filed as: BACHER GERALD
12 granted patents·48 pending applications·78 citations·filing 2000–2013
88Inventor score
Files withBEVEC DORIAN39ZIOPHARM ONCOLOGY INC4AETERNA ZENTARIS GMBH3BACHER GERALD1BAXTER HEALTHCARE SA1
Top patents by PatentIndex Score
60 records- 0187US6693119B2Indolyl-3-glyoxylic acid derivatives having therapeutically valuable propertiesBAXTER HEALTHCARE SA·Filed 2000·Granted Feb 17, 2004·28 cites·12 claims
- 0286US6432987B2Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor actionZENTARIS AG·Filed 2000·Granted Aug 13, 2002·32 cites·10 claims
- 0376US7452910B2Indolyl-3-glyoxylic acid derivatives having therapeutically valuable propertiesZIOPHARM ONCOLOGY INC·Filed 2003·Granted Nov 18, 2008·7 cites·13 claims
- 0470US8349805B2Use of Gonadorelin as a therapeutic agentMONDOBIOTECH LAB AG·Filed 2008·Granted Jan 8, 2013·3 cites·4 claims
- 0570US2010190713A1Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0670US2010184708A1Use of gly-pro-glu-oh (gpe) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0770US2010234306A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0870US2010197585A1Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0970US2010184698A1Use of a deslorelin and mastoparan as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1068US8211856B2Use of somatostatin-14 as a therapeutic agentBEVEC DORIAN·Filed 2008·Granted Jul 3, 2012·1 cites·3 claims
- 1168US8193149B2Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicineBEVEC DORIAN·Filed 2008·Granted Jun 5, 2012·1 cites·4 claims
- 1268US8178489B2Formulation for aviptadilBACHER GERALD·Filed 2006·Granted May 15, 2012·2 cites·20 claims
- 1368US7365081B2Indole derivatives and their use as medicamentsAETERNA ZENTARIS GMBH·Filed 2001·Granted Apr 29, 2008·4 cites·9 claims
- 1468US2008241274A1Indibulin therapyZIOPHARM ONCOLOGY INC·Filed 2007·Application pending·0 cites
- 1565US2010210553A1Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-arg as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1663US2010210532A1Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1763US2010210558A1Minigastrin as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1863US2010184677A1Use of the human pancreatic polypeptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1963US2010190716A1Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2063US2010273701A1Use of salusin beta alone or in combination with octreotide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2163US2010190711A1Big gastrin i as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2263US2010210536A1Use of leptin (22-56 ) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2363US2010197601A1Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infectionBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2463US2010197608A1Use of melanotrophin-potentiating factor as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2563US2014193519A1Indibulin therapyZIOPHARM ONCOLOGY INC·Filed 2013·Application pending·0 cites
- 2662US2010197603A1Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infectionsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2762US2010190724A1Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infectionDORIAN BEVEC·Filed 2008·Application pending·0 cites
- 2862US2010204112A1Use of tyr-w-mif-1 and urocortin 2 as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2962US2010216724A1Use of fibronectin fragment (196-203 ) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3061US8008324B2Indole derivatives and their use as medicamentAETERNA ZENTARIS GMBH·Filed 2008·Granted Aug 30, 2011·0 cites·11 claims
- 3161US2013084345A1Indibulin therapyZIOPHARM ONCOLOGY INC·Filed 2012·Application pending·0 cites
- 3260US2010204116A1Use of calcitonin as anti-angiogenic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3360US2010197605A1Therapeutic use of peptide yglf and combination with kvlpvpqBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3460US2010197586A1Use of secretin and optionally urodilatin as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3560US2010184674A1Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3660US2010197599A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3760US2010204152A1Use of gluten exorphin c : as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3860US2010197587A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3960US2010197588A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4060US2010184676A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4160US2010256043A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4259US7989453B2Indole derivatives and their use as medicamentAETERNA ZENTARIS GMBH·Filed 2007·Granted Aug 2, 2011·0 cites·2 claims
- 4358US2010210561A1Use of peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4458US2010210539A1Use of peptide ll-37 as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4558US2010292132A1Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4657US2010184678A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4757US2010216722A1Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4855US2008057124A1Indolyl-3-glyoxylic acid derivatives having therapeutically valuable propertiesNICKEL BERND·Filed 2007·Application pending·0 cites
- 4954US8541364B2Use of a octreotide as a therapeutic agentBEVEC DORIAN·Filed 2008·Granted Sep 24, 2013·0 cites·3 claims
- 5054US8338380B2Use of the peptide RFMWMR as a therapeutic agentBEVEC DORIAN·Filed 2008·Granted Dec 25, 2012·0 cites·3 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gerald Bacher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →